PRTC
PureTech Health PLC
NASDAQ: PRTC · HEALTHCARE · BIOTECHNOLOGY
$17.40
-4.08% today
Updated 2026-04-29
Market cap
$441.56M
P/E ratio
10.67
P/S ratio
69.09x
EPS (TTM)
$1.70
Dividend yield
—
52W range
$15 – $20
Volume
0.0M
PureTech Health PLC (PRTC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.40
12-Month target
$19.23
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -11.09% (capped 20%) · P/E: 10.67x (capped 25x) · Margin: 793.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.